EichorEICHOR
Condition: De Escalation Therapy Synced from ClinicalTrials.gov · August 07, 2026

Recruiting studies: De Escalation Therapy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Efficacy of Nab-PHP Versus TCbHP in Neoadjuvant Therapy for HER2-positive Early Breast Cancer
Phase 3 · 1 location(s) · Henan Cancer Hospital · NCT07057427De-escalation of Ustekinumab Therapy in Patients With Crohn's Disease and Ulcerative Colitis
Phase 4 · 1 location(s) · McGill University Health Centre/Research Institute of the Mc · NCT07303686Early De-escalation of Empirical Antibiotics Treatment for Neutropenic Fever
NA · 1 location(s) · Shanghai Jiao Tong University School of Medicine · NCT04270786Reduced-dose RT With/Without CCT Versus Standard CCRT for High-risk LANPC Who Achieved CR Post Induction Chemotherapy
Phase 3 · 1 location(s) · Sun Yat-sen University · NCT06092957Step-down Therapy After Long-term Osteoporosis Treatment
Phase 4 · 1 location(s) · National Taiwan University Hospital · NCT07281586Skipping Hormone Therapy in Low-Risk Early Breast Cancer
Phase 2 · 41 location(s) · UNICANCER · NCT07661927Evaluating the De-Escalation of Surveillance for Patients Who Have Undergone Curative Treatment for Primary Breast Cance
NA · 1 location(s) · Royal College of Surgeons, Ireland · NCT07616258Decreasing Treatment for Metastatic HER2-Positive Breast Cancer With Undectable Cancer Levels in Blood Tests.
Phase 2 · 1 location(s) · UNICANCER · NCT06450314Subcutaneous Interval Lengthening of Vedolizumab for Economic Research
Phase 4 · 1 location(s) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC · NCT06584162Assessment of an Early De-Escalation to a Low-potency Single Antiplatelet Therapy Guided by Genetics Versus a Systematic
Phase 3 · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05577988A Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat Cancer
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT05491512Deescalation of Endocrine Therapy Duration in Women With HR+ HER2- Breast Cancer at Very Low Risk
Phase 2 · 2 location(s) · UNICANCER · NCT05297617Tailoring Bleeding Reduction Approaches in Patients Undergoing PCI
Phase 4 · 1 location(s) · University of Florida · NCT05681702Reduced-dose vs Standard-dose Irradiation for Low-risk Clinical Target Volume in Nasopharyngeal Carcinoma.
Phase 3 · 6 location(s) · Sun Yat-sen University · NCT07201337Efficacy of Cotrimoxazole as a De-escalation Treatment of Ventilator-Associated Pneumonia in Intensive Care Unit
Phase 3 · 30 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05696093Ticagrelor De-escalation Strategy in AMI Patients
Phase 4 · 1 location(s) · Dong-A University · NCT04755387De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Eq
Phase 3 · 832 location(s) · NRG Oncology · NCT04852887THERApy De-escalation for TESTicular Cancer
Phase N/A · 1 location(s) · Queen Mary University of London · NCT06309745A Prospective Randomized Non-inferiority Trial Comparing Anti-CD20 Maintenance Versus De-Escalation Strategy In Relapsin
Phase 3 · 1 location(s) · University Hospital, Montpellier · NCT07189325Primary RPLND Versus Systemic Chemotherapy in Good-prognosis Metastatic Testicular Cancer
NA · 1 location(s) · Sahlgrenska University Hospital · NCT07498959Pilot Randomized Study for Treatment Volume De-Escalation for Spinal Metastases With Stereotactic Body Radiation Therapy
NA · 1 location(s) · IRCCS Sacro Cuore Don Calabria di Negrar · NCT07538024Four Cycles Taxane With Trastuzumab and Pertuzumab Neoadjuvant Therapy Among Low Risk HER2 Positive Patients
Phase N/A · 1 location(s) · Shu Wang · NCT06722599Evaluating the De-Escalation of Surveillance for Patients Who Have Undergone Curative Treatment for Breast Cancer
Phase N/A · 1 location(s) · Royal College of Surgeons, Ireland · NCT07572370ctDNA-Guided De-Escalation of Adjuvant Chemotherapy With Dalpiciclib in HR-Positive/HER2-Negative Breast Cancer
Phase 2 · 1 location(s) · Peking University People's Hospital · NCT06970912De-escalation of Radiation Dose in HPV-associated OPC Utilising FMISO PET (DE-RADIATE)
NA · 1 location(s) · Royal North Shore Hospital · NCT06307015A Study of Lower Dose Radiation Therapy for People With Prostate Cancer
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT07635238MRI-Guided Neoadjuvant Treatment De-Escalation in Stage II-III TNBC
Phase 2 · 2 location(s) · Tel-Aviv Sourasky Medical Center · NCT07327021PSMA-PET Guided De-escalation of Salvage Radiation Treatment in Recurrent Prostate Cancer
Phase 2 · 1 location(s) · University of Nebraska · NCT07234981ctDNA to Predict Response to Chemo-Immunotherapy and Detect Minimal Residual Disease in Non-Small Cell Lung Cancer
Phase 2 · 1 location(s) · University of Miami · NCT06902272Compartmentalized Postoperative Radiotherapy in Head and Neck Cancer
Phase 2 · 3 location(s) · Olgun Elicin · NCT07058805
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.